Susan Scott

This discussion features Dr. Susan Scott, a thoracic medical oncologist from Johns Hopkins, who specializes in lung cancer treatment. She delves into the latest options for metastatic non-small cell lung cancer, such as osimertinib and various chemotherapy combinations. The significance of comprehensive NGS testing and adjusting treatment plans based on patient responses is emphasized. Scott also provides insights into managing side effects and the role of immunotherapy in treatment, highlighting the importance of patient choices in their care.